卵巢癌中的干系驱动集群:免疫特征和预后影响
Xinyan Zeng1,2, Wentian Wu3, Xiaoqin Li1,2
1Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Frontiers in oncology
|June 26, 2025
概括
这项研究确定了卵巢癌 (OC) 中的新型茎性相关子组,揭示了AKAP12作为潜在的治疗点. 这一发现为精密治疗的新策略提供了新的机会.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 卵巢癌 (OC) 是一种流行的妇科恶性瘤.
- 癌症干与治疗耐药性,复发和OC的不良预后有关.
- 与茎相关的亚型及其在OC中的治疗意义尚未得到充分理解.
研究的目的:
- 在OC中识别与茎相关的基因和分子子组.
- 开发一个预后模型并研究瘤微环境 (TME) 和免疫景观.
- 探索AKAP12在OC进展中的作用及其与免疫检查点的关联.
主要方法:
- 进行比较的转录组分析和无监督的聚类,以定义OC子组.
- 权重基因共同表达网络分析 (WGCNA) 和LASSO回归用于预后建模.
- 单细胞RNA测序,功能测定和免疫组织化学验证发现.
主要成果:
- 确定了三种不同的与茎状相关的OC子组,预后和免疫特征不同.
- 在TME中的纤维细胞显著有助于保持茎状特征.
- AKAP12与茎结度具有积极的相关性,其降低可减少OC进展并增强西斯胺的敏感性.
结论:
- 一个与茎状性相关的新型基因特征有助于OC诊断预测和治疗分层.
- AKAP12成为潜在的生物标志物和治疗点,用于干性驱动的OC.
- 这项研究为精准医学在卵巢癌治疗中开辟了新的途径.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


